Table of Contents
PharmSights
| Hsp70 ATPase Modulators as Therapeutics for Alzheimer’s and other Neurodegenerative Diseases |
Abstract PDF |
| Umesh K. Jinwal, John Koren III, John C. O’Leary III, Jeffrey R. Jones, Jose F. Abisambra, Chad A. Dickey |
43-46 |
| Potency of Claudin-targeting as Antitumor Therapy |
Abstract PDF |
| Rie Saeki, Masuo Kondoh, Hiroshi Uchida, Kiyohito Yagi |
47-51 |
| Lansoprazole, a Proton Pump Inhibitor, to Reduce Gastrointestinal Inflammation via Heme Oxygenase-1 Induction |
Abstract PDF |
| Yuji Naito, Tomohisa Takagi, Toshikazu Yoshikawa |
53-60 |
Research Articles
| Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family |
Abstract PDF |
| Qin He, Jingxue Shi, Hong Sun, Jie An, Ying Huang, M. Saeed Sheikh |
61-68 |
Reviews
| Decision Making by p53: Life versus Death |
Abstract PDF |
| Lingyan Jiang, M. Saeed Sheikh, Ying Huang |
69-77 |
FDA Corner
| FDA Approves New Use of Xifaxan for Patients with Liver Disease |
Abstract PDF |
| |
79 |
| FDA Approves Therapy to Treat Gaucher Disease |
Abstract PDF |
| |
79 |
| FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia |
Abstract PDF |
| |
80 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
